(1s,3r,5r,6s,8r,10r,11s,15r,16s,20r,21r,22r,23r,24r,25r,26r,27r,28r)-5,10,15,20-tetrakis(hydroxymethyl)-2,4,7,9,12,14,17,19-octaoxapentacyclo[16.2.2.2~3,6~.2~8,11~.2~13,16~]octacosane-21,22,23,24,25,26,27,28-octol

Term ID

CHEBI:229909

Synonyms

(1S,5R,6S,8R,10R,11S,13R,15R,16S,20R,21R,22R,23R,24R,25R,26R,27R,28R)-5,10,15,20-tetrakis(hydroxymethyl)-2,4,7,9,12,14,17,19-octaoxapentacyclo[16.2.2.23,6.28,11.213,16]octacosane-21,22,23,24,25,26,27,28-octol

Definition

References

Chemspider:388477
KEGG:C00973

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from (1s,3r,5r,6s,8r,10r,11s,15r,16s,20r,21r,22r,23r,24r,25r,26r,27r,28r)-5,10,15,20-tetrakis(hydroxymethyl)-2,4,7,9,12,14,17,19-octaoxapentacyclo[16.2.2.2~3,6~.2~8,11~.2~13,16~]octacosane-21,22,23,24,25,26,27,28-octol

Phenotype where environments contain (1s,3r,5r,6s,8r,10r,11s,15r,16s,20r,21r,22r,23r,24r,25r,26r,27r,28r)-5,10,15,20-tetrakis(hydroxymethyl)-2,4,7,9,12,14,17,19-octaoxapentacyclo[16.2.2.2~3,6~.2~8,11~.2~13,16~]octacosane-21,22,23,24,25,26,27,28-octol

Phenotype modified by environments containing (1s,3r,5r,6s,8r,10r,11s,15r,16s,20r,21r,22r,23r,24r,25r,26r,27r,28r)-5,10,15,20-tetrakis(hydroxymethyl)-2,4,7,9,12,14,17,19-octaoxapentacyclo[16.2.2.2~3,6~.2~8,11~.2~13,16~]octacosane-21,22,23,24,25,26,27,28-octol

Phenotype affecting (1s,3r,5r,6s,8r,10r,11s,15r,16s,20r,21r,22r,23r,24r,25r,26r,27r,28r)-5,10,15,20-tetrakis(hydroxymethyl)-2,4,7,9,12,14,17,19-octaoxapentacyclo[16.2.2.2~3,6~.2~8,11~.2~13,16~]octacosane-21,22,23,24,25,26,27,28-octol

Human Disease Model